Astrazeneca PLC Sponsored ADR (AZN)

66.21
1.67 2.59
NASDAQ
Prev Close 64.54
Open 65.48
Day Low/High 64.98 / 66.36
52 Wk Low/High 53.63 / 71.70
Volume 7.17M
Exchange NASDAQ
P/E Ratio 51.70
Div & Yield N.A. (N.A)
Emergent BioSolutions Turns Bearish, So Beware

Emergent BioSolutions Turns Bearish, So Beware

A break in a key support level could precipitate further declines in the life sciences company's shares.

Hopping on a Couple Compelling Opportunities in a Market That Isn't

Hopping on a Couple Compelling Opportunities in a Market That Isn't

Dips in the shares of Redhill Biopharma and FibroGen Inc. provided the chance for the author to employ his covered call strategy.

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Dynavax Technologies has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream.

SPAC Mania, My Short-Sale Rule, Inflation, Bumble IPO, Rivian, Trading Nvidia

SPAC Mania, My Short-Sale Rule, Inflation, Bumble IPO, Rivian, Trading Nvidia

Who knew high finance was so easy? And why the heck was I working so hard? Fundamental analysis is so 1980s.

Lunchtime Reading

Here are some articles that I'll be perusing while I choke down my lunch today:  American Airlines Uncorks Wine Delivery Program To Clear Shelves, Promote Travel MyFreeCams hack: 2 million user records stolen from top adult streaming site and sold o...

The Correction in AstraZeneca Could Be Nearing an End

The Correction in AstraZeneca Could Be Nearing an End

Aggressive traders might want to look past any near-term price weakness and consider a small long position.

Jim Cramer: Here's My Plan to Distribute the Vaccine

Jim Cramer: Here's My Plan to Distribute the Vaccine

We have to take both the private sector and the states out of the equation, and adopt the process that wiped out Polio.

Assessing AstraZeneca in the Fight Against the Virus

Assessing AstraZeneca in the Fight Against the Virus

While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.

$2000 Delayed, Covid-19 Mutation, Trading Intel

$2000 Delayed, Covid-19 Mutation, Trading Intel

I did something on Tuesday that I never thought that I would do again. I bought some Intel.

I've Come Around to Thinking of Boeing as an Investment

I've Come Around to Thinking of Boeing as an Investment

I think BA returns to normal as we do, as the airlines do... but with the defense contracting business as a foundation to rely upon.

Broad Rally, Tipping the Scales, What to Expect From the Fed, Trading Apple

Broad Rally, Tipping the Scales, What to Expect From the Fed, Trading Apple

The Russell 2000 is now up 7% for December, twice the increase for the Nasdaq Composite.

Jim Cramer: Market Sees Successful Vaccine Rollout as a Long Shot

Jim Cramer: Market Sees Successful Vaccine Rollout as a Long Shot

Ending the pandemic swiftly appears unlikely, so here's how to look at key stocks and sectors right now -- especially as concerns of new lockdowns grow.

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

BioXcel Therapeutics and Avadel Pharmaceuticals would make good additions to the portfolios of larger drug companies.

A Glance Behind, Sifting Through Events to Come, Waiting for Santa

A Glance Behind, Sifting Through Events to Come, Waiting for Santa

Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).

Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights

Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights

Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.

Real Money Post Industrial Average Climbs 9.5% Over November

Real Money Post Industrial Average Climbs 9.5% Over November

The RMPIA also tops other indexes for year, shooting ahead 29%.

What If AstraZeneca's Covid-19 Vaccine Doesn't Work?

What If AstraZeneca's Covid-19 Vaccine Doesn't Work?

Governments around the world have committed to buying hundreds of millions of doses of AZD1222.

Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting

Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting

The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.

Jim Cramer: The 10 Tipping Points That Took Us to Dow 30,000

Jim Cramer: The 10 Tipping Points That Took Us to Dow 30,000

All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.

November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks

November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks

Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.

Jim Cramer: If the End of the Covid Era Is in Sight, Here Are the Stocks to Buy

Jim Cramer: If the End of the Covid Era Is in Sight, Here Are the Stocks to Buy

I will come back to these names over and over again as we are now in the sweet spot for many.

Big News Is Followed by Little Moves

Big News Is Followed by Little Moves

A lot has happened over the past couple weeks, but little has changed. Let's dig in.

Jim Cramer: Just How Will the Covid-19 Vaccines Be Distributed?

Jim Cramer: Just How Will the Covid-19 Vaccines Be Distributed?

None of these questions have been answered which is why I see chaos ahead as we can't even imagine this process working.

Broadening Market Performance, the Vaccine 'Put', Trading McKesson

Broadening Market Performance, the Vaccine 'Put', Trading McKesson

Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.

Asia's Worst-Performing Stock Market Suddenly Becomes Its Best

Asia's Worst-Performing Stock Market Suddenly Becomes Its Best

The stock market in the Philippines has surged by one-fifth in just over a month amid reasons for optimism.

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

A look at the charts of Advanced Micro Devices and Tesla, plus a review of the 'broadening' market action from Thursday.

The Trap Door, Winter Arrives Early, Lesson of Hiroo Onoda, Fading Consumer

The Trap Door, Winter Arrives Early, Lesson of Hiroo Onoda, Fading Consumer

Technical analysis has become so much more accurate a trading tool than it ever was before.

It's Finally Time for Energy Stocks

It's Finally Time for Energy Stocks

One of the most-hated sectors of the market is taking off, and it's not too late to get on board.

Election Hindsight, Treasury Yields, Fed Day, Chip Stock Setup, A Great Trade

Election Hindsight, Treasury Yields, Fed Day, Chip Stock Setup, A Great Trade

The most important market takeaway right now is that both the Nasdaq Composite and S&P 500 have filled their respective gaps and retaken their 50-day simple moving averages.